目的 分析咸陽市中心醫(yī)院2018—2020年住院藥房胰島素的使用情況和特點，為臨床合理用藥提供參考。方法 利用咸陽市中心醫(yī)院“HIS”系統(tǒng)調(diào)取2018—2020年住院藥房胰島素使用情況數(shù)據(jù)，對其種類、消耗量、銷售金額、使用頻度（DDDs）、日均費用（DDC）和排序比（B/A）進行統(tǒng)計和分析。結(jié)果 2018—2019年有17種胰島素供臨床使用，2020年新增3種長效胰島素，總銷售金額呈平穩(wěn)下降趨勢；胰島素注射液在住院藥房的使用中占有很高比例，長效甘精胰島素注射液（長秀霖）次之；胰島素各品種的金額和DDDs排序無顯著波動，排名基本穩(wěn)定。結(jié)論 本院胰島素使用基本合理，應(yīng)根據(jù)不同患者的特點采取不同治療措施，盡量做到個體化給藥，確保臨床用藥規(guī)范合理。

Objective To investigate the utilization and characteristics of insulin for injection in inpatient department of Xianyang Central Hospital, and to provide reference for rational use of drugs.Methods The utilization of insulin for injection in inpatient department of Xianyang Central Hospital from 2018 to 2020 were analyzed statistically by “HIS” in terms of species, consumption sum, defined daily doses (DDDs), defined daily cost (DDC), and sorting ratio (B/A). Results From 2018 to 2019, there were 17 insulin kinds for clinical use, three new long-acting insulins will be added in 2020, and the sales amount showed a downward trend. The sales amount of Insulin Injection ranked the first for three consecutive years, followed by Insulin Glargine Injection. There was no significant fluctuation in the amount and DDDs of insulin varieties. The ranking was basically stable.Conclusion The usage of insulin therapy is basal reasonable, and should be different according to individual characteristics to ensure that the use of drugs is standardized and reasonable.

R977